Entero Healthcare Solutions Ltd

AI
Entero Healthcar Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Entero Healthcare Solutions Ltd

₹ 1,971 -1.67%
12 Nov - close price
enterohealthcare.com BSE: 544122 NSE: ENTERO
About

Incorporated in 2018, Entero Healthcare
Solutions Ltd is in the business of distribution
and marketing of pharmaceutical and surgical products and allied services[1]

Key Points

Business Overview:[1]
EHSL, a leading Healthcare Supply Chain Solutions Specialist, ranks among India’s top three healthcare product distributors by revenue, offering demand fulfillment and generation solutions to manufacturers.

Website BSE NSE
  • Market Cap ₹ 8,586 Cr.
  • Current Price ₹ 1,971
  • High / Low ₹ 2,138 / 944
  • Stock P/E 250
  • Book Value ₹ 393
  • Dividend Yield 0.00 %
  • ROCE 2.19 %
  • ROE 1.75 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 29.3% CAGR over last 5 years

Cons

  • Stock is trading at 5.01 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has a low return on equity of 3.09% over last 3 years.
  • Earnings include an other income of Rs.104 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Retailing Pharmacy Retail

Part of Nifty Microcap 250 Nifty Total Market BSE Consumer Discretionary BSE 1000 Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
74 77 107 122 113 101 72 79 83 107 79 83 115
83 85 116 124 119 112 84 93 96 121 101 93 103
Operating Profit -9 -8 -9 -2 -6 -10 -12 -14 -13 -14 -23 -10 12
OPM % -12% -11% -9% -1.5% -5% -10% -16% -17% -15% -13% -29% -12% 10%
17 16 42 32 29 28 -21 26 24 19 40 23 22
Interest 7 5 6 0 0 0 0 1 1 1 3 6 6
Depreciation 2 2 2 2 2 2 2 3 3 3 3 3 3
Profit before tax -2 1 26 28 20 14 -36 9 8 1 12 5 24
Tax % -6% -36% -44% 25% 24% 26% -22% 24% 25% 42% -11% 25% 21%
-2 1 37 21 15 11 -28 7 6 1 13 3 19
EPS in Rs -1.33 0.59 8.57 4.80 3.52 2.48 -6.39 1.60 1.31 0.19 3.08 0.79 4.40
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
56 105 137 178 318 409 348 384
73 137 191 222 353 439 411 418
Operating Profit -17 -32 -54 -44 -34 -30 -63 -35
OPM % -30% -30% -39% -25% -11% -7% -18% -9%
21 23 27 53 90 67 109 104
Interest 1 2 5 11 22 2 5 15
Depreciation 4 7 9 10 9 9 12 12
Profit before tax -2 -18 -41 -12 24 27 30 42
Tax % 0% 0% 0% 0% -58% 28% 11%
-2 -18 -41 -12 38 19 27 37
EPS in Rs -162.67 -1,811.38 -106.10 -30.31 8.84 4.41 6.18 8.46
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 27%
3 Years: 25%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 29%
3 Years: 63%
TTM: -20%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 74%
Return on Equity
10 Years: %
5 Years: %
3 Years: 3%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 0.10 0.10 4 4 43 44 44 44
Reserves -13 -31 -72 -84 1,583 1,607 1,640 1,669
457 540 674 775 18 14 133 220
21 23 47 68 125 139 342 297
Total Liabilities 466 533 654 764 1,769 1,804 2,158 2,230
46 50 51 41 34 28 47 47
CWIP 2 2 0 0 0 0 2 0
Investments 38 39 39 41 41 277 825 909
380 442 563 682 1,694 1,498 1,283 1,273
Total Assets 466 533 654 764 1,769 1,804 2,158 2,230

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-52 -68 -45 -57 -76 -109 -60
-167 -7 -69 -58 -763 208 -132
178 76 127 91 926 -41 98
Net Cash Flow -41 0 14 -24 87 58 -94
Free Cash Flow -75 -75 -47 -57 -77 -111 -75
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 293% 215% 81% 124% 214% 305% 89%

Ratios

Standalone / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 114 107 139 153 130 89 108
Inventory Days 206 177 103 68 65 110 85
Days Payable 101 48 99 132 88 87 87
Cash Conversion Cycle 219 236 143 89 107 112 107
Working Capital Days 2,013 1,201 1,034 947 850 432 303
ROCE % -3% -6% -0% 4% 5% 2%

Insights

In beta
Dec 2018 Dec 2019 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cumulative Acquisitions (since inception)
count

Log in to view insights

Please log in to see hidden values.

Login
Districts Covered
count
Healthcare Product Manufacturer Relationships
count
Number of Hospital Customers
count
Number of Retail Customers (Pharmacies)
count
Number of SKUs Handled
count
Number of Warehouses
count
Entero Growth Outperformance vs IPM (multiplier)
x

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

11 Recently
Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
52.44% 52.44% 52.44% 52.44% 52.42% 52.42% 52.42% 52.42% 52.42% 52.40% 52.40%
23.30% 23.32% 23.82% 22.20% 19.92% 17.21% 14.68% 5.14% 4.03% 4.36% 5.76%
2.28% 2.06% 7.73% 8.78% 9.63% 10.19% 9.64% 16.42% 16.62% 15.48% 21.16%
21.99% 22.18% 16.02% 16.59% 18.03% 20.19% 23.26% 26.03% 26.94% 27.77% 20.67%
No. of Shareholders 80,86466,40036,76733,17233,15933,33836,33440,33339,08439,70940,919

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls